argenx SE (ARGX): Among the Best Growth Stocks to Buy and Hold for the Long Term - Yahoo Finance
6 days ago • Google News
argenx NV ADR (ARGX)
US$ 622.92991.27%
Price Chart
Key Statistics
Market Cap
$ 35.3B
P/E Ratio
35.21
Revenue (TTM)
$ 2.64B
Volume
432.21K
52W High
$ 678.21
52W Low
$ 358.80
Dividend Yield
0.00%
Beta
0.17
Technicals
50-Day MA
592.0196
200-Day MA
587.341
52 Week High
678.21
52 Week Low
358.8
About ARGX
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The compa.
Employees
1599
Headquarters
Amsterdam, Netherlands
CEO
Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Latest News
argenx Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg